Tower Research Capital LLC (Trc) Celyad Oncology Sa Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.72 - $4.08 $2,107 - $4,998	-1,225 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.56 - $5.0 $4,361 - $6,125	1,225 New	1,225 $4,000
Q3 2019 Nov 05, 2019	SELL	$9.6 - $14.88 $9 - $14	-1 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$10.94 - $22.64 $426 - $882	-39 Reduced 97.5%	1 $0
Q1 2019 May 14, 2019	SELL	$19.76 - $24.56 $1,323 - $1,645	-67 Reduced 62.62%	40 $1,000

Q4 2018 Feb 14, 2019	BUY	$16.0 - $28.17 $1,712 - $3,014	107 New	107 $2,000
Q2 2018 Aug 15, 2018	SELL	$26.05 - $35.15 $833 - $1,124	-32 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$34.1 - $47.52 $3,955 - $5,512	-116 Reduced 78.38%	32 $1,000
Q4 2017 Feb 09, 2018	BUY	$35.81 - $64.0 $4,261 - $7,616	119 Added 410.34%	148 $6,000
Q3 2017 Nov 14, 2017	BUY	$40.0 - $57.3 $1,160 - $1,661	29	29 $2,000

Ticker CYAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,594,000
Market Cap $11.7M
Description
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cance...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.